Metraipolis › archive › dc_f482cf5dec1a
Real-World Effectiveness of Polymerized House-Dust-Mite Subcutaneous Immunotherapy up to 24 Months: Why Baseline Symptom Severity Shapes Measurement of the… — Europe PMC PMID:42652786
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42652786
- DOI
- 10.3390/jcm15166383
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T03:14:13.981Z
- SHA-256 of the archived text
8a025e40299b5d8ddb42d9cccd5259f47d30f262ca1161caa7222b58646af7ee- Stable URL of this page
https://metraipolis.com/documento/dc_f482cf5dec1a
How to cite
Real-World Effectiveness of Polymerized House-Dust-Mite Subcutaneous Immunotherapy up to 24 Months: Why Baseline Symptom Severity Shapes Measurement of the… — Europe PMC PMID:42652786 — Europe PMC (en), https://europepmc.org/article/MED/42652786 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f482cf5dec1a (Metraipolis archive dc_f482cf5dec1a, sha256 8a025e40299b5d8ddb42d9cccd5259f47d30f262ca1161caa7222b58646af7ee)
BibTeX
@misc{dcf482cf5dec1a,
title = {Real-World Effectiveness of Polymerized House-Dust-Mite Subcutaneous Immunotherapy up to 24 Months: Why Baseline Symptom Severity Shapes Measurement of the… — Europe PMC PMID:42652786},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42652786},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f482cf5dec1a; sha256 8a025e40299b5d8ddb42d9cccd5259f47d30f262ca1161caa7222b58646af7ee},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42652786. Agents can read the archived copy with the MCP tool read_document.